Seer (SEER) Projected to Post Quarterly Earnings on Wednesday

Key Points

• Seer (NASDAQ: SEER) will announce its Q2 2025 earnings on August 6th, with analysts predicting losses of $0.39 per share and revenue of $3.75 million.
• In the previous earnings report, Seer reported a loss of $0.34 per share, surpassing estimates, but still faced a negative return on equity of 24.69%.
• Goldman Sachs Group Inc. increased its stake in Seer by 51.6%, indicating growing institutional interest in the company.

Seer (NASDAQ:SEER - Get Free Report) is expected to be releasing its Q2 2025 earnings data after the market closes on Wednesday, August 6th. Analysts expect Seer to post earnings of ($0.39) per share and revenue of $3.75 million for the quarter. Seer has set its FY 2025 guidance at EPS.

Seer (NASDAQ:SEER - Get Free Report) last posted its quarterly earnings results on Tuesday, May 13th. The company reported ($0.34) earnings per share for the quarter, topping analysts' consensus estimates of ($0.37) by $0.03. The firm had revenue of $4.21 million for the quarter, compared to analyst estimates of $3.25 million. Seer had a negative net margin of 560.90% and a negative return on equity of 24.69%. On average, analysts expect Seer to post $-1 EPS for the current fiscal year and $-2 EPS for the next fiscal year.

Seer Price Performance

SEER traded up $0.01 on Friday, reaching $2.13. 107,673 shares of the company's stock were exchanged, compared to its average volume of 87,860. The stock has a market cap of $125.39 million, a PE ratio of -1.51 and a beta of 1.57. Seer has a twelve month low of $1.59 and a twelve month high of $2.63. The stock's fifty day moving average price is $2.12 and its 200-day moving average price is $2.08.

Insiders Place Their Bets

In related news, Director Dipchand Nishar sold 30,253 shares of the business's stock in a transaction dated Friday, June 13th. The shares were sold at an average price of $2.08, for a total transaction of $62,926.24. Following the transaction, the director directly owned 49,204 shares in the company, valued at approximately $102,344.32. The trade was a 38.07% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Insiders own 11.28% of the company's stock.

Hedge Funds Weigh In On Seer

An institutional investor recently raised its position in Seer stock. Jane Street Group LLC lifted its stake in Seer, Inc. (NASDAQ:SEER - Free Report) by 33.3% during the 1st quarter, according to the company in its most recent filing with the SEC. The fund owned 254,174 shares of the company's stock after acquiring an additional 63,432 shares during the quarter. Jane Street Group LLC owned 0.43% of Seer worth $430,000 at the end of the most recent reporting period. Institutional investors and hedge funds own 75.20% of the company's stock.

Seer Company Profile

Seer, Inc, a life sciences company, engages in developing and commercializing products to decode the biology of the proteome. It develops Proteograph Product Suite, an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation, and software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab for research use only.